Volume 99, Issue 5

Search all International Journal of Hematology articles

May 2014

Including PIH Articles on Noncoding RNA in hematopoietic system

22 articles in this issue

Pan-ocular hemorrhage in thrombotic thrombocytopenic purpura
Aniruddha Agarwal
Jagat Ram
Images in Hematology 23 March 2014 Pages: 527 - 528
Guest editorial: noncoding RNA in hematopoietic system
Ai Kotani
Progress in Hematology 04 April 2014 Pages: 529 - 530
Long noncoding RNAs during normal and malignant hematopoiesis
Juan R. Alvarez-Dominguez
Wenqian Hu
Harvey F. Lodish
Progress in Hematology 09 March 2014 Pages: 531 - 541
Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias
Sho Ikeda
Hiroyuki Tagawa
Progress in Hematology 25 February 2014 Pages: 542 - 552
Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesis
Kazuki Okuyama
Jun Ogata
Ai Kotani
Progress in Hematology 01 April 2014 Pages: 553 - 560
Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice
Yusuke Sasaki
Mariko Noguchi-Sasaki
Yasushi Shimonaka
Original Article 13 March 2014 Pages: 561 - 569
Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia
Koji Kawaguchi
Kousaku Matsubara
Takashi Fukaya
Original Article 13 March 2014 Pages: 570 - 576
Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor
Kenichi Ogiwara
Keiji Nogami
Midori Shima
Original Article 01 April 2014 Pages: 577 - 587
Laboratory tests for coagulation system monitoring in a patient with β-thalassemia
Elena A. Seregina
Olga F. Nikulina
Fazoil I. Ataullakhanov
Original Article 09 March 2014 Pages: 588 - 596
Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia
Yoshihito Morimoto
Nao Yoshida
Koji Kato
Original Article 27 February 2014 Pages: 597 - 602
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia
Limin Liu
Yanming Zhang
Depei Wu
Original Article 13 March 2014 Pages: 603 - 608
ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases
Michinori Aoe
Akira Shimada
Tsuneo Morishima
Original Article 21 March 2014 Pages: 609 - 615
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study
Michele Baccarani
Brian J. Druker
On behalf of the TOPS investigators
Original Article 23 March 2014 Pages: 616 - 624
JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
Yoko Edahiro
Soji Morishita
Norio Komatsu
Original Article 28 March 2014 Pages: 625 - 634
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes
Yundeok Kim
In-Ho Kim
Korean Society of Hematology Acute myeloid Leukemia/Myelodysplastic Syndrome Working Party
Original Article 20 March 2014 Pages: 635 - 643
Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group
Nobuharu Fujii
Koichi Nakase
Mitsune Tanimoto
Original Article 15 March 2014 Pages: 644 - 651
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning
Shinsuke Takagi
Hideki Araoka
Shuichi Taniguchi
Original Article 25 March 2014 Pages: 652 - 658
A novel mutation of the transcobalamin II gene in an infant presenting with hemophagocytic lymphohistiocytosis
Selma Unal
Ozlem Tezol
Yesim Oztas
Case Report 22 February 2014 Pages: 659 - 662
Complete remission of Sweet’s syndrome after azacytidine treatment for concomitant myelodysplastic syndrome
Sara Martinelli
Gian Matteo Rigolin
Antonio Cuneo
Case Report 20 February 2014 Pages: 663 - 667
Spontaneous regression of essential thrombocythemia with MPL mutation on menopause
Maki Otsuka
Shuichi Hanada
Haruhiko Ohashi
Case Report 09 March 2014 Pages: 668 - 670
Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells
Ayako Arai
Takeshi Yamaguchi
Osamu Miura
Case Report 19 March 2014 Pages: 671 - 675
Erratum to: A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning
Shinsuke Takagi
Hideki Araoka
Shuichi Taniguchi
Erratum 17 April 2014 Pages: 676 - 676

Volume 99, Issue 5

Pan-ocular hemorrhage in thrombotic thrombocytopenic purpura

Guest editorial: noncoding RNA in hematopoietic system

Long noncoding RNAs during normal and malignant hematopoiesis

Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias

Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesis

Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice

Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia

Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor

Laboratory tests for coagulation system monitoring in a patient with β-thalassemia

Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia

Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia

ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases

Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study

JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan

Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes

Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group

A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning

A novel mutation of the transcobalamin II gene in an infant presenting with hemophagocytic lymphohistiocytosis

Complete remission of Sweet’s syndrome after azacytidine treatment for concomitant myelodysplastic syndrome

Spontaneous regression of essential thrombocythemia with MPL mutation on menopause

Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells

Erratum to: A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning

Navigation